Clinical Trial Detail

NCT ID NCT02013154
Title A Study of DKN-01 in Combination With Paclitaxel
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Leap Therapeutics, Inc.
Indications

esophagus squamous cell carcinoma

gastroesophageal junction adenocarcinoma

esophagus adenocarcinoma

Therapies

DKN-01 + Paclitaxel

Age Groups: adult senior

No variant requirements are available.